This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.
Keywords: Antibody therapy; Blood–CSF barrier; Blood–brain barrier; Blood–retinal barrier; Drug delivery; Liposomal technology; MicroRNA; Neuroinflammation; Protein capsules; Viral vectors.